Actelion, which has previously been courted by French drugmaker Sanofi as well as J&J, said "there can be no assurance any transaction will result from these discussions."
J&J confirmed the exclusive negotiations.
News that makes sense
Your trusted source for staying up-to-date with the world around you. Get free daily news updates and analysis, straight to your inbox.
(Reporting by John Revill; Editing by Michael Shields)
Share
